TrialJournal of thrombosis and haemostasis : JTH2021

Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.

Walter Ageno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.